PELLERINO, Alessia

PELLERINO, Alessia  

Mostra records
Risultati 1 - 20 di 78 (tempo di esecuzione: 0.042 secondi).
Titolo Data di pubblicazione Autore(i) File
A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups 2021 Gao Y.; Wei L.; Kim S.J.; Wang L.; He Y.; Zheng Y.; Bertero L.; Pellerino A.; Cassoni P.; Tamagnone L.; Theresa P.K.; Deutsch A.; Zhan H.; Lai J.; Wang Y.; You H.
A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study 2023 Wei, Li; Gao, Yuting; Prochazka, Katharina Theresa; Liu, Rongqiu; Wang, Liang; Liu, Boyang; He, Yingzhi; Bertero, Luca; Pellerino, Alessia; Cassoni, Paola; Tamagnone, Luca; Deutsch, Alexander J; Zhan, Huien; Lai, Jing; Kim, Seok Jin; You, Hua
An approach to the timing of altered localization of TDP-43 in ALS motor neurons during disease progression 2009 Giordana MT; Grifoni S; Piccinini M; Pellerino A; De Marco G ; Buccinnà B ; Lupino E ; Naldi A; Magistrello M; Rinaudo MT
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter? 2023 Pellerino, Alessia; Bruno, Francesco; Soffietti, Riccardo; Rudà, Roberta
Antiangiogenic therapy of brain tumors: The role of bevacizumab 2014 Trevisan, Elisa; Bertero, Luca; Bosa, Chiara; Magistrello, Michela; Pellerino, Alessia; Rudà, Roberta; Soffietti, Riccardo
Biomarker for Frontotemporal Lobar Degeneration (FTLD) with TDP-43 Pathology: the Circulating Lymphocytes 2012 Pellerino A; Lomartire A; Naldi A; Buccinna B; Maffeo E; Ramondetti C; Lupino E; Rinaudo MT; Piccinini M; Rainero I; De Marco G; Giordana MT
Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance 2021 Mo, Francesca; Pellerino, Alessia; Soffietti, Riccardo; Rudà, Roberta
Brain metastasis from HER2-positive breast cancer: an evolving landscape 2022 Soffietti, Riccardo; Pellerino, Alessia
Choosing appropriate chemotherapy for diffusely infiltrating WHO grade II gliomas in adults. 2020 Pellerino A, Bertero L, RudA R, Soffietti R
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand? 2022 Alessia Pellerino, Francesco Bruno, Rosa Palmiero, Edoardo Pronello, Luca Bertero, Riccardo Soffietti, Roberta Rudà
Complete response of spinal metastases from non-small cell lung cancer with ALK inhibitors 2019 Pellerino A.; Buffoni L.; Ruda R.; Soffietti R.
Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016 2019 Rudà, Roberta; Pellerino, Alessia; Pace, Andrea; Carapella, Carmine Maria; Dealis, Cristina; Caroli, Manuela; Faedi, Marina; Bello, Lorenzo; Migliore, Enrica; Marchese, Giulia; Bertero, Luca; Cassoni, Paola; Soffietti, Riccardo
Current clinical management of elderly patients with glioma 2020 Pellerino, Alessia; Bruno, Francesco; Internò, Valeria; Ruda', Roberta; Soffietti, Riccardo
Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review. 2011 Giordana MT; Ferrero P; Grifoni S; Pellerino A; Naldi A; Montuschi A.
Depatuxizumab mafodotin (Depatux-M) plus temozolomide (TMZ) in recurrent glioblastoma patients: Real-world experience from a multicenter study of Italian Association of Neuro-Oncology (AINO) 2020 Mario Caccese, Marta Padovan, Marica Eoli, Alessia Pellerino, Simona Rizzato, Claudia Caserta, Matteo Simonelli, Maria Michiara, Vittorina Zagonel, Roberta Ruda, Giuseppe Lombardi
Depatuxizumab mafodotin (Depatux-m) plus temozolomide in recurrent glioblastoma patients: Real-world experience from a multicenter study of italian association of neuro-oncology (aino) 2021 Padovan M.; Eoli M.; Pellerino A.; Rizzato S.; Caserta C.; Simonelli M.; Michiara M.; Caccese M.; Anghileri E.; Cerretti G.; Ruda R.; Zagonel V.; Lombardi G.
Diagnosis and Treatment of Peripheral and Cranial Nerve Tumors with Expert Recommendations: An EUropean Network for RAre CANcers (EURACAN) Initiative 2023 Pellerino, Alessia; Verdijk, Robert M.; Nichelli, Lucia; Andratschke, Nicolaus H.; Idbaih, Ahmed; Goldbrunner, Roland
Does valproic acid affect tumor growth and improve survival in glioblastomas? 2016 Rudà, Roberta; Pellerino, Alessia; Soffietti, Riccardo
Effects of Levetiracetam and Lacosamide on survival and seizure control in IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy 2023 Bianconi, Andrea; Koumantakis, Emanuele; Gatto, Andrea; Zeppa, Pietro; Saaid, Ayoub; Nico, Elsa; Bruno, Francesco; Pellerino, Alessia; Rizzo, Francesca; Junemann, Carola Vera; Melcarne, Antonio; Garbossa, Diego; Dalmasso, Paola; Cofano, Fabio
Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016 2019 Ruda R.; Pellerino A.; Pace A.; Carapella C.M.; Dealis C.; Caroli M.; Faedi M.; Bello L.; Migliore E.; Marchese G.; Bertero L.; Cassoni P.; Soffietti R.